Charles Schwab Investment Management Inc Castle Biosciences Inc Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 258,866 shares of CSTL stock, worth $5.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

258,866

Previous 274,761 5.79%

Holding current value

$5.16 Million

Previous $7.84 Million 11.97%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$26.52 - $34.67 $421,535 - $551,079	-15,895 Reduced 5.79%	258,866 $6.9 Million
Q3 2024 Nov 12, 2024	BUY	$17.4 - $31.47 $685,855 - $1.24 Million	39,417 Added 16.75%	274,761 $7.84 Million
Q2 2024 Aug 12, 2024	BUY	$18.84 - $24.94 $572,867 - $758,350	30,407 Added 14.84%	235,344 $5.12 Million
Q1 2024 May 08, 2024	SELL	$18.06 - $25.3 $42,585 - $59,657	-2,358 Reduced 1.14%	204,937 $4.54 Million
Q4 2023 Feb 06, 2024	BUY	$12.19 - $22.43 $76,870 - $141,443	6,306 Added 3.14%	207,295 $4.47 Million
Q3 2023 Nov 08, 2023	BUY	$13.28 - $20.3 $199,120 - $304,378	14,994 Added 8.06%	200,989 $3.39 Million
Q2 2023 Aug 09, 2023	BUY	$11.66 - $26.0 $27,156 - $60,554	2,329 Added 1.27%	185,995 $2.55 Million
Q1 2023 May 11, 2023	SELL	$19.47 - $28.49 $16,938 - $24,786	-870 Reduced 0.47%	183,666 $4.17 Million
Q4 2022 Feb 13, 2023	BUY	$18.08 - $30.0 $124,932 - $207,300	6,910 Added 3.89%	184,536 $4.34 Million
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $148,228 - $225,997	6,585 Added 3.85%	177,626 $4.63 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $78,848 - $226,638	4,928 Added 2.97%	171,041 $3.76 Million
Q1 2022 May 13, 2022	BUY	$33.17 - $46.98 $139,247 - $197,222	4,198 Added 2.59%	166,113 $7.45 Million
Q4 2021 Feb 11, 2022	BUY	$39.06 - $67.58 $136,397 - $235,989	3,492 Added 2.2%	161,915 $6.94 Million
Q3 2021 Nov 16, 2021	BUY	$60.13 - $77.6 $1.51 Million - $1.95 Million	25,170 Added 18.89%	158,423 $10.5 Million
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $831,462 - $1.28 Million	16,606 Added 14.24%	133,253 $9.77 Million
Q1 2021 May 17, 2021	BUY	$58.92 - $97.33 $683,177 - $1.13 Million	11,595 Added 11.04%	116,647 $7.99 Million
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $851,333 - $1.43 Million	19,526 Added 22.83%	105,052 $7.06 Million
Q3 2020 Nov 13, 2020	BUY	$38.47 - $52.03 $2.4 Million - $3.24 Million	62,304 Added 268.3%	85,526 $4.4 Million
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $16,913 - $26,666	620 Added 2.74%	23,222 $876,000
Q1 2020 May 15, 2020	BUY	$23.08 - $35.53 $283,122 - $435,846	12,267 Added 118.69%	22,602 $674,000
Q4 2019 Feb 07, 2020	BUY	$15.74 - $35.04 $162,672 - $362,138	10,335 New	10,335 $356,000

Others Institutions Holding CSTL

# of Institutions

209

Shares Held

25.9M

Call Options Held

128K

Put Options Held

35.4K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $524M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Castle Biosciences Inc Transaction History